Update on the Genetics of and Systemic Therapy Options for Combined Hepatocellular Cholangiocarcinoma
Combined hepatocellular-cholangiocarcinoma (cHCC-ICC) is an uncommon and aggressive form of primary liver cancer. Currently, there are no international guidelines for optimal management. For localized tumors, radical resection represents the preferred treatment option, whereas for advanced tumors, s...
Main Authors: | Alexander A. Azizi, Andreas V. Hadjinicolaou, Carla Goncalves, Adam Duckworth, Bristi Basu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-09-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.570958/full |
Similar Items
-
Diagnostic performance of LI-RADS version 2018 in differentiating hepatocellular carcinoma from other hepatic malignancies in patients with hepatitis B virus infection
by: Shuo Shao, et al.
Published: (2020-01-01) -
Clinicopathological features and recurrence patterns of combined hepatocellular-cholangiocarcinoma
by: Takamichi Ishii, et al.
Published: (2020-12-01) -
Patients' prognosis of intrahepatic cholangiocarcinoma and combined hepatocellular‐cholangiocarcinoma after resection
by: Peipei Song, et al.
Published: (2019-10-01) -
Combined hepatocellular-cholangiocarcinoma: a population level analysis of incidence and mortality trends
by: Jiakun Wang, et al.
Published: (2019-02-01) -
YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role
by: Matthias Van Haele, et al.
Published: (2019-02-01)